• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Risk interaction of obesity, insulin resistance and hormone-sensitive lipase promoter polymorphisms (LIPE-60 C > G) in the development of fatty liver.肥胖、胰岛素抵抗和激素敏感脂肪酶启动子多态性(LIPE-60C>G)在脂肪肝发展中的风险交互作用。
BMC Med Genet. 2013 May 20;14:54. doi: 10.1186/1471-2350-14-54.
2
MTTP-297H polymorphism reduced serum cholesterol but increased risk of non-alcoholic fatty liver disease-a cross-sectional study.MTTP-297H 多态性降低血清胆固醇但增加非酒精性脂肪性肝病风险:一项横断面研究。
BMC Med Genet. 2015 Oct 12;16:93. doi: 10.1186/s12881-015-0242-6.
3
The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population.载脂蛋白基因 PNPLA3 I148M 多态性与血糖正常人群的胰岛素抵抗和非酒精性脂肪性肝病相关。
Liver Int. 2011 Oct;31(9):1326-31. doi: 10.1111/j.1478-3231.2011.02526.x. Epub 2011 Apr 5.
4
Impact of sterol regulatory element-binding factor-1c polymorphism on incidence of nonalcoholic fatty liver disease and on the severity of liver disease and of glucose and lipid dysmetabolism.固醇调节元件结合蛋白-1c 多态性对非酒精性脂肪性肝病的发生率及肝脏疾病严重程度和糖脂代谢紊乱的影响。
Am J Clin Nutr. 2013 Oct;98(4):895-906. doi: 10.3945/ajcn.113.063792. Epub 2013 Aug 28.
5
Sex differences in the association between adipose insulin resistance and non-alcoholic fatty liver disease in Chinese adults.中国成年人中脂肪组织胰岛素抵抗与非酒精性脂肪肝之间的性别差异。
Biol Sex Differ. 2023 Oct 9;14(1):69. doi: 10.1186/s13293-023-00549-0.
6
Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver.非酒精性脂肪肝的瘦白种人受试者的临床和代谢特征
Am J Gastroenterol. 2017 Jan;112(1):102-110. doi: 10.1038/ajg.2016.318. Epub 2016 Aug 16.
7
Divergent pathways of liver fat accumulation, oxidation, and secretion in lipodystrophy versus obesity-associated NAFLD.脂肪营养不良与肥胖相关的非酒精性脂肪性肝病中肝脏脂肪堆积、氧化和分泌的不同途径。
Liver Int. 2023 Dec;43(12):2692-2700. doi: 10.1111/liv.15707. Epub 2023 Aug 25.
8
Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, and ameliorates steatosis.肝脏中激素敏感性脂肪酶和脂肪甘油三酯脂肪酶的过表达促进脂肪酸氧化,刺激游离脂肪酸的直接释放,并改善脂肪变性。
J Biol Chem. 2008 May 9;283(19):13087-99. doi: 10.1074/jbc.M800533200. Epub 2008 Mar 12.
9
Association of the hormone sensitive lipase -60C > G variant with fasting insulin levels in healthy young men.激素敏感脂肪酶-60C>G变异与健康年轻男性空腹胰岛素水平的关联。
Nutr Metab Cardiovasc Dis. 2002 Aug;12(4):173-7.
10
The TNF-alpha gene NcoI polymorphism at position -308 of the promoter influences insulin resistance, and increases serum triglycerides after postprandial lipaemia in familiar obesity.启动子-308位的肿瘤坏死因子-α基因NcoI多态性影响胰岛素抵抗,并在家族性肥胖患者餐后血脂异常后增加血清甘油三酯水平。
Clin Chem Lab Med. 2003 Apr;41(4):501-10. doi: 10.1515/CCLM.2003.076.

引用本文的文献

1
Hemoglobin A1c and abdominal obesity as predictors of diabetes and ASCVD in individuals with prediabetes in UK Biobank: a prospective observational study.血红蛋白A1c和腹型肥胖作为英国生物银行中糖尿病前期个体发生糖尿病和动脉粥样硬化性心血管疾病的预测因素:一项前瞻性观察研究。
Cardiovasc Diabetol. 2024 Dec 19;23(1):448. doi: 10.1186/s12933-024-02525-3.
2
Case report: First Chinese patient with family partial lipodystrophy type 6 due to novel compound heterozygous mutations in the LIPE gene.病例报告:首例因LIPE基因新型复合杂合突变导致的中国家族性部分性脂肪营养不良6型患者。
Front Genet. 2024 Jul 24;15:1417613. doi: 10.3389/fgene.2024.1417613. eCollection 2024.
3
Variation in the Gene and Its Association with Carcass and Meat Quality Traits in Yak.牦牛基因变异及其与胴体和肉质性状的关联
Animals (Basel). 2023 Dec 1;13(23):3720. doi: 10.3390/ani13233720.
4
The protective roles of augmenter of liver regeneration in hepatocytes in the non-alcoholic fatty liver disease.肝脏再生增强因子在非酒精性脂肪性肝病中对肝细胞的保护作用。
Front Pharmacol. 2022 Oct 11;13:928606. doi: 10.3389/fphar.2022.928606. eCollection 2022.
5
Itemization difference of patient-reported outcome in patients with chronic liver disease.患者报告结局在慢性肝病患者中的项目化差异。
PLoS One. 2022 Feb 22;17(2):e0264348. doi: 10.1371/journal.pone.0264348. eCollection 2022.
6
Association of MTTP gene variants with pediatric NAFLD: A candidate-gene-based analysis of single nucleotide variations in obese children.MTTP基因变异与儿童非酒精性脂肪性肝病的关联:基于候选基因的肥胖儿童单核苷酸变异分析
PLoS One. 2017 Sep 27;12(9):e0185396. doi: 10.1371/journal.pone.0185396. eCollection 2017.
7
Human Genetic Ancestral Composition Correlates with the Origin of Mycobacterium leprae Strains in a Leprosy Endemic Population.人类遗传祖先组成与麻风病流行人群中麻风杆菌菌株的起源相关。
PLoS Negl Trop Dis. 2015 Sep 11;9(9):e0004045. doi: 10.1371/journal.pntd.0004045. eCollection 2015.
8
Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study.血清游离脂肪酸水平与非酒精性脂肪性肝病的关联:一项横断面研究。
Sci Rep. 2014 Jul 25;4:5832. doi: 10.1038/srep05832.

本文引用的文献

1
Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c.肝脂肪变性:从头合成和转录因子 SREBP-1c 的作用。
Diabetes Obes Metab. 2010 Oct;12 Suppl 2:83-92. doi: 10.1111/j.1463-1326.2010.01275.x.
2
Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites.肝脂肪毒性与非酒精性脂肪性肝炎发病机制:非甘油三酯脂肪酸代谢物的核心作用
Hepatology. 2010 Aug;52(2):774-88. doi: 10.1002/hep.23719.
3
Expression of fatty acid synthase in nonalcoholic fatty liver disease.脂肪酸合酶在非酒精性脂肪性肝病中的表达
Int J Clin Exp Pathol. 2010 Mar 25;3(5):505-14.
4
A fresh look at NASH pathogenesis. Part 1: the metabolic movers.重新审视 NASH 发病机制。第 1 部分:代谢推动者。
J Gastroenterol Hepatol. 2010 Apr;25(4):672-90. doi: 10.1111/j.1440-1746.2010.06253.x.
5
Extracellular fatty acid synthase: a possible surrogate biomarker of insulin resistance.细胞外脂肪酸合酶:胰岛素抵抗的一个可能替代生物标志物。
Diabetes. 2010 Jun;59(6):1506-11. doi: 10.2337/db09-1756. Epub 2010 Mar 18.
6
From the metabolic syndrome to NAFLD or vice versa?从代谢综合征到非酒精性脂肪性肝病,或者反之亦然?
Dig Liver Dis. 2010 May;42(5):320-30. doi: 10.1016/j.dld.2010.01.016. Epub 2010 Mar 6.
7
The developmental origins, mechanisms, and implications of metabolic syndrome.代谢综合征的发育起源、机制及意义。
J Nutr. 2010 Mar;140(3):648-52. doi: 10.3945/jn.109.111179. Epub 2010 Jan 27.
8
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications.肥胖与非酒精性脂肪性肝病:生化、代谢及临床意义。
Hepatology. 2010 Feb;51(2):679-89. doi: 10.1002/hep.23280.
9
Visceral obesity and metabolic syndrome: two faces of the same medal?内脏型肥胖与代谢综合征:同一枚硬币的两面?
Intern Emerg Med. 2010 Apr;5(2):111-9. doi: 10.1007/s11739-009-0332-6. Epub 2009 Dec 9.
10
The inflamed liver and atherosclerosis: a link between histologic severity of nonalcoholic fatty liver disease and increased cardiovascular risk.炎症性肝脏与动脉粥样硬化:非酒精性脂肪性肝病组织学严重程度与心血管风险增加之间的联系。
Dig Dis Sci. 2010 Sep;55(9):2644-50. doi: 10.1007/s10620-009-1075-y. Epub 2009 Dec 5.

肥胖、胰岛素抵抗和激素敏感脂肪酶启动子多态性(LIPE-60C>G)在脂肪肝发展中的风险交互作用。

Risk interaction of obesity, insulin resistance and hormone-sensitive lipase promoter polymorphisms (LIPE-60 C > G) in the development of fatty liver.

机构信息

Department of Internal Medicine, Division of Endocrinology and Metabolism, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.

出版信息

BMC Med Genet. 2013 May 20;14:54. doi: 10.1186/1471-2350-14-54.

DOI:10.1186/1471-2350-14-54
PMID:23688034
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3673851/
Abstract

BACKGROUND

Hormone sensitive lipase (HSL) promoter (LIPE-60 C > G) polymorphism has been found to be involved in hepatic steatosis, obesity, diabetes and dyslipidemia. The precise interactions between these risk factors and genetic susceptibility that may affect non-alcoholic fatty liver disease (NAFLD) are still not fully determined.

METHODS

A cross-sectional study was conducted in 1056 men. To avoid the confounding effect of plasma glucose, the study population was classified into normal glucose tolerance (NGT, n = 729) and glucose intolerance (GI, n = 299) groups. NAFLD was diagnosed by abdominal ultrasound after ruling out any history of alcohol abuse. A multivariate regression model was used to estimate the impact of these factors on NAFLD.

RESULTS

In the NGT group, subjects with NAFLD often have complicated metabolic abnormalities. The coexistence of NAFLD and GI has been demonstrated to have a synergistic effect raising BMI, serum insulin and HOMA-insulin resistance (HOMA-IR). BMI and adipose-insulin resistance (Adipo-IR), but not HOMA-IR, significantly contributed to a greater risk of developing NAFLD. Serum triglyceride was significantly up-regulated in men with the (CG + GG) genotype of HSL promoter polymorphism, NAFLD and Adiopo-IR in sequence.

CONCLUSION

Adipo-IR, rather than HOMA-IR, appears to be a consistent insulin resistance index in the study of NAFLD. G allele of the HSL promoter polymorphism may contribute the greatest impact raising serum triglyceride in a state of glucose intolerance.

摘要

背景

激素敏感脂肪酶(HSL)启动子(LIPE-60C>G)多态性与肝脂肪变性、肥胖、糖尿病和血脂异常有关。这些危险因素与遗传易感性之间的确切相互作用可能影响非酒精性脂肪性肝病(NAFLD),但尚未完全确定。

方法

对 1056 名男性进行了横断面研究。为了避免血糖的混杂影响,将研究人群分为正常糖耐量(NGT,n=729)和糖耐量受损(GI,n=299)两组。在排除任何酒精滥用史后,通过腹部超声诊断 NAFLD。使用多元回归模型来估计这些因素对 NAFLD 的影响。

结果

在 NGT 组中,患有 NAFLD 的患者通常存在复杂的代谢异常。已经证明,NAFLD 与 GI 的共存具有协同作用,会导致 BMI、血清胰岛素和 HOMA 胰岛素抵抗(HOMA-IR)升高。BMI 和脂肪胰岛素抵抗(Adipo-IR),而不是 HOMA-IR,显著增加了发生 NAFLD 的风险。HSL 启动子多态性 CG+GG 基因型、NAFLD 和 Adiopo-IR 依次出现的男性血清甘油三酯水平显著升高。

结论

在 NAFLD 的研究中,Adipo-IR 似乎比 HOMA-IR 更能反映一致性胰岛素抵抗。HSL 启动子多态性的 G 等位基因可能在葡萄糖耐量受损的情况下对升高血清甘油三酯产生最大影响。